spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

BioIVT Webinar Will Discuss How to Optimize Microbiome Research

Sample collection and processing techniques play a crucial role in ensuring that research results represent the complete microbiome

BioIVT, a leading provider of research models and services for drug development, today announced that it is hosting a webinar entitled “The Microbiome: Understanding Why Collection and Processing Matters” at 11 a.m. ET on July 25.

The human microbiome is comprised of all the microorganisms – whether beneficial, neutral or harmful – found in or on the human body.

“Since the Human Microbiome Project was launched in 2007, scientific knowledge and understanding of the human microbiome’s role in health and disease have grown dramatically. An individual’s microbiome is now known to impact their overall health, disease severity, and response to medications. In fact, a person’s microbiome is thought to be able to control their pathogens, immune system and mood!” said Mark Driscoll, PhD, Shoreline Biome co-founder.

“As we learn more about the potent impact that an individual’s microbiome can have on their overall health, the desire to harness it to improve health outcomes increases,” said Cathie G. Miller, PhD, BioIVT director of product marketing, personalized medicine. “To optimize microbiome research, scientists need access to high quality disease-state and control samples, which have been collected and processed using standardized, highly reproducible techniques. That is one of BioIVT’s areas of expertise.”

This webinar, which will be co-presented by Drs. Driscoll and Miller, will discuss best practices for securing representative samples of all microbes within a biospecimen.

Drs. Driscoll and Miller will outline optimal sample collection, processing and assay techniques. They will also discuss the importance of sample lysis and primer design and how to select the most appropriate sequencing platform and database mapping approach. In addition, they will review a case study with webinar attendees.

BioIVT has the largest network of IRB-approved sample collection sites in the industry, together with an extensive inventory of the highest quality disease-state and control biospecimens. Samples are available for a wide range of conditions, including Crohn’s disease, ulcerative colitis, irritable bowel disease, celiac disease, functional abdominal pain syndrome, and diarrhea. Furthermore, BioIVT works closely with its clients and has the ability to customize all aspects of its sample collection and storage processes.

Interested parties can register for this complimentary one-hour webinar at http://info.bioivt.com/microbiome-collection-webinar-registration.

About BioIVT

BioIVT, formerly BioreclamationIVT, is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. Our PHASEZERO® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the premier supplier of ADME-toxicology model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly-discovered compounds and their effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in elevating science. For more information, please visit www.bioivt.com or follow the company on Twitter @BioIVT.
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PCI and CSP Technologies, Inc. Announce Strategic Collaboration for Breakthrough Activ-BlisterTM Solutions

Philadelphia, PA & Auburn, AL – September 17, 2018 PCI Pharma Services (PCI), a full-service provider of specialist outsourced drug manufacturing, clinical trial services, and commercial packaging to the global healthcare industry, is pleased to announce its exclusive collaboration agreement with CSP Technologies, Inc. for U.S. clinical trials and stability testing utilizing Activ-BlisterTM packaging solutions, which help protect and promote speed-to-market for pharmaceutical and medical device products with heightened susceptibility to moisture and gases, especially oxygen.
More info >>


White Papers

Inhaler Adherence: Exploring Key Factors

Aptar Pharma

Aptar Pharma recently hosted an expert panel roundtable on “Inhaler Adherence”. This international scientific forum was held in Paris, France on November 29th 2013. The roundtable was organized to explore and exchange views on the issues which may influence inhaler adherence/ compliance with a particular focus on asthma and C.O.P.D. therapies and their corresponding inhaler devices (MDIs, DPIs).
More info >>

Industry Events

6th Annual Single Cell Analysis Congress

8-9 November 2018, London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement